Kevin Popp

Title: Kevin Popp - Innovator in Therapeutic Gas Release Systems

Introduction

Kevin Popp is a notable inventor based in Neustadt an der Aisch, Germany. He has made significant contributions to the field of therapeutic gas release systems, particularly for oral administration. His innovative approach aims to improve treatment options for gastrointestinal diseases.

Latest Patents

Kevin Popp holds a patent for a "Membrane-based two component therapeutic gas release system for oral administration." This invention discloses a therapeutic gas release system that comprises a therapeutic gas releasing compound A and a therapeutic gas release triggering compound B. These compounds are separated by an inner septum during storage, and they are surrounded by an outer membrane that is gas-permeable and water- and solid-impermeable, preferably a silicone membrane. The therapeutic gas release is activated before oral administration by breaking the inner septum. This system is designed to treat (inflammatory) diseases of the gastrointestinal tract.

Career Highlights

Kevin Popp is affiliated with the University of Würzburg, where he continues to advance his research and development in therapeutic technologies. His work has garnered attention for its potential impact on medical treatments.

Collaborations

Kevin collaborates with esteemed colleagues such as Lorenz Meinel and Cornelius Hermann, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kevin Popp's contributions to the field of therapeutic gas release systems highlight his commitment to improving healthcare solutions. His innovative patent reflects a significant advancement in the treatment of gastrointestinal diseases.